Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.

Ossid: Thermoformer

See it at PACK EXPO International, Booth #S-3636! Ossid, a product brand of ProMach, introduces the FP-420 thermoforming machine that can package a variety of proteins. Packaging formats include vacuum skin pack, vacuum, and modified atmosphere. It operates at between 5 and 10 cycles/min.

FP-420
FP-420

The FP-420 conforms to the IP 65 washdown standard. The FP-420 is easy to operate and fast to changeover – less than 30 min. This machine includes production reporting capabilities and the option for secure remote diagnostics. FP-420 customers have the benefit of a single point of contact for printers, labelers, product feeders/loaders, fillers, pre-heat stations, prototyping services, and package development.

Fill out the form below to request more information about Ossid: Thermoformer
Conveying Innovations Report
Editors report on distinguishing characteristics that define each new product and collected video demonstrating the equipment or materials as displayed at the show. This topical report, winnowed from nearly 300 PACK EXPO collective booth visits, represents a categorized, organized account of individual items that were selected based on whether they were deemed to be both new, and truly innovative, based on decades of combined editorial experience in experiencing and evaluating PACK EXPO products.
Take me there
Conveying Innovations Report
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report